Ausgabe 1/2019
Inhalt (26 Artikel)
Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy
Elaine M. Walsh, Aliaa Shalaby, Mark O’Loughlin, Nessa Keane, Mark J Webber, Michael J. Kerin, Maccon M. Keane, Sharon A. Glynn, Grace M. Callagy
Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
Raquel N. Rozner, Azael Freites-Martinez, Jerry Shapiro, Eliza B. Geer, Shari Goldfarb, Mario E. Lacouture
Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials
Rafael Caparica, Marco Bruzzone, Francesca Poggio, Marcello Ceppi, Evandro de Azambuja, Matteo Lambertini
Trends in use of bilateral prophylactic mastectomy vs high-risk surveillance in unaffected carriers of inherited breast cancer syndromes in the Inherited Cancer Registry (ICARE)
Danielle A. Henry, Marie C. Lee, Deanna Almanza, Kamran A. Ahmed, Weihong Sun, David C. Boulware, Christine Laronga
Survivorship issues in older breast cancer survivors
Steven S. Coughlin, Raheem J. Paxton, Nicole Moore, Jessica Lynn Stewart, Judith Anglin
Identification, clinical-pathological characteristics and treatment outcomes of patients with metastatic breast cancer and somatic human epidermal growth factor receptor 2 (ERBB2) mutations
Lynn Jongen, Giuseppe Floris, Bram Boeckx, Dominiek Smeets, Diether Lambrechts, Sara Vander Borght, Annouschka Laenen, Grace Mann, Richard E. Cutler Jr., Alshad S. Lalani, Patrick Neven, Hans Wildiers
GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation
Jingjing Liu, Lei Liu, Ernesto Yagüe, Qianxi Yang, Teng Pan, Hui Zhao, Yunhui Hu, Jin Zhang
Glutamate dehydrogenase (GLUD1) expression in breast cancer
Madeleine L. Craze, Rokaya El-Ansari, Mohammed A. Aleskandarany, Kiu Wai Cheng, Lutfi Alfarsi, Brendah Masisi, Maria Diez-Rodriguez, Christopher C. Nolan, Ian O. Ellis, Emad A. Rakha, Andrew R. Green
Connexin 43 is an independent predictor of patient outcome in breast cancer patients
Maria Chasampalioti, Andrew R. Green, Ian O. Ellis, Emad A. Rakha, Andrew M. Jackson, Ian Spendlove, Judith M. Ramage
Prognostic impact and possible pathogenesis of lymph node metastasis in ductal carcinoma in situ of the breast
Rika Yonekura, Tomo Osako, Takuji Iwase, Akiko Ogiya, Takayuki Ueno, Masanobu Kitagawa, Shinji Ohno, Futoshi Akiyama
ANXA2 expression in African American triple-negative breast cancer patients
Lee D. Gibbs, Pankaj Chaudhary, Kelsey Mansheim, Richard J. Hare, Rebecca A. Mantsch, Jamboor K. Vishwanatha
G-protein-coupled estrogen receptor GPER-1 expression in hormone receptor-positive breast cancer is associated with poor benefit of tamoxifen
Tanja Ignatov, Maria Claus, Norbert Nass, Johannes Haybaeck, Bernd Seifert, Thomas Kalinski, Olaf Ortmann, Atanas Ignatov
Plasma exosomes stimulate breast cancer metastasis through surface interactions and activation of FAK signaling
Tatiana Shtam, Stanislav Naryzhny, Roman Samsonov, David Karasik, Igor Mizgirev, Artur Kopylov, Elena Petrenko, Yana Zabrodskaya, Roman Kamyshinsky, Daniil Nikitin, Maxim Sorokin, Anton Buzdin, Hava Gil-Henn, Anastasia Malek
A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer
Daniel P. Hollern, Cristina M. Contreras, Stephanie Dance-Barnes, Grace O. Silva, Adam D. Pfefferle, Jessie Xiong, David B. Darr, Jerry Usary, Kevin R. Mott, Charles M. Perou
A phase II study investigating the acute toxicity of targeted intraoperative radiotherapy as tumor-bed boost plus whole breast irradiation after breast-conserving surgery in Korean patients
Sung Gwe Ahn, Soong June Bae, Hak Woo Lee, Chang Ik Yoon, Jun Won Kim, Ik Jae Lee, Joon Jeong
Meta-analysis of upgrade rates in 3163 radial scars excised after needle core biopsy diagnosis
Gelareh Farshid, Elizabeth Buckley
Evaluation of radiation-induced cardiac toxicity in breast cancer patients treated with Trastuzumab-based chemotherapy
Mohamed Abouegylah, Lior Z. Braunstein, Mohamed A. Alm El-Din, Andrzej Niemierko, Laura Salama, Mostafa Elebrashi, Samantha K. Edgington, Kyla Remillard, Brian Napolitano, George E. Naoum, Hoda E. Sayegh, Tessa Gillespie, Mohamed Farouk, Abdelsalam A. Ismail, Alphonse G. Taghian
A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study
Elisabet Lidbrink, E. Chmielowska, B. Otremba, A. Bouhlel, S. Lauer, M. Liste Hermoso, E. Nüesch, M. Shing, V. Misra
Impact of preexisting mental illness on breast cancer endocrine therapy adherence
Cole B. Haskins, Bradley D. McDowell, Ryan M. Carnahan, Jess G. Fiedorowicz, Robert B. Wallace, Brian J. Smith, Elizabeth A. Chrischilles
Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype
Daniel T. Dibaba, Kemi Ogunsina, Dejana Braithwaite, Tomi Akinyemiju
Sleep duration and risk of breast cancer: The JACC Study
Jinhong Cao, Ehab S. Eshak, Keyang Liu, Isao Muraki, Renzhe Cui, Hiroyasu Iso, Akiko Tamakoshi, Akiko Tamakoshi, Mitsuru Mori, Yoshihiro Kaneko, Ichiro Tsuji, Yosikazu Nakamura, Hiroyasu Iso, Kazumasa Yamagishi, Haruo Mikami, Michiko Kurosawa, Yoshiharu Hoshiyama, Naohito Tanabe, Koji Tamakoshi, Kenji Wakai, Shinkan Tokudome, Koji Suzuki, Shuji Hashimoto, Hiroshi Yatsuya, Shogo Kikuchi, Yasuhiko Wada, Takashi Kawamura, Yoshiyuki Watanabe, Kotaro Ozasa, Kazuya Mikami, Chigusa Date, Kiyomi Sakata, Yoichi Kurozawa, Takesumi Yoshimura, Yoshihisa Fujino, Akira Shibata, Naoyuki Okamoto, Hideo Shio
Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort
Brian L. Sprague, Pamela M. Vacek, Sally D. Herschorn, Ted A. James, Berta M. Geller, Amy Trentham-Dietz, Janet L. Stein, Donald L. Weaver
A nationwide study of breast cancer, depression, and multimorbidity among hospitalized women and men in the United States
Roger J. Zoorob, Jason L. Salemi, Maria C. Mejia de Grubb, Sanjukta Modak, Robert S. Levine
Milk intake and mammographic density in premenopausal women
Yunan Han, Xiaoyu Zong, Yize Li, Graham A. Colditz, Adetunji T. Toriola
MDM2, MDM2-C, and mutant p53 expression influence breast cancer survival in a multiethnic population
Lenora W. M. Loo, Chong Gao, Yurii B. Shvetsov, Danielle R. Okoro, Brenda Y. Hernandez, Jill Bargonetti
The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis
Kirsty Wai Chung Lee, Sally Lord, Richard S. Finn, Elgene Lim, Andrew Martin, Sherene Loi, Jodi Lynch, Michael Friedlander, Chee Khoon Lee